Matches in Wikidata for { <http://www.wikidata.org/entity/Q95381194> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q95381194 description "article scientifique publié en 2014" @default.
- Q95381194 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95381194 description "wetenschappelijk artikel" @default.
- Q95381194 description "наукова стаття, опублікована в лютому 2014" @default.
- Q95381194 name "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 name "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 type Item @default.
- Q95381194 label "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 label "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 prefLabel "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 prefLabel "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 P1433 Q95381194-48BA0E39-C56B-472C-88B6-FC2D44468DEE @default.
- Q95381194 P1476 Q95381194-17D13286-F06C-4C46-8F7A-E1A972DA19DF @default.
- Q95381194 P304 Q95381194-E242D3BC-7017-46CF-9705-65D883F40F72 @default.
- Q95381194 P31 Q95381194-9F813116-9EAA-4050-BE8D-0471D5138354 @default.
- Q95381194 P433 Q95381194-F27CFB5C-6759-4B6E-930B-98A3630B7CDB @default.
- Q95381194 P478 Q95381194-0FC05EB8-AC77-4C4A-AD3B-A64CBC99DDB8 @default.
- Q95381194 P577 Q95381194-F9C8C3AC-9D5D-4BC9-8863-48786CEDB2F8 @default.
- Q95381194 P698 Q95381194-F6AF4223-B0BE-4D5B-9E2F-5837335B11E5 @default.
- Q95381194 P921 Q95381194-22872A52-A792-4251-BFE9-B687A8180FFB @default.
- Q95381194 P921 Q95381194-35867500-2E43-4B49-8D4E-44E4B835614A @default.
- Q95381194 P921 Q95381194-865B9185-5C2A-4D61-992F-9A0323D1AEE9 @default.
- Q95381194 P921 Q95381194-C12198BA-B66D-4EAB-B8F3-0FC6BAC1B832 @default.
- Q95381194 P698 24852788 @default.
- Q95381194 P1433 Q26867024 @default.
- Q95381194 P1476 "A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial" @default.
- Q95381194 P304 "6-7" @default.
- Q95381194 P31 Q13442814 @default.
- Q95381194 P433 "2 Suppl 5" @default.
- Q95381194 P478 "12" @default.
- Q95381194 P577 "2014-02-01T00:00:00Z" @default.
- Q95381194 P698 "24852788" @default.
- Q95381194 P921 Q418817 @default.
- Q95381194 P921 Q42824440 @default.
- Q95381194 P921 Q637059 @default.
- Q95381194 P921 Q7168693 @default.